Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

Bibliographic Details
Main Authors: Phillips KA, Milne RL, Rookus MA, Goldgar D, Friedlander M, McLachlan SA, Buys S, Antoniou AC, Birch K, Terry MB, Easton DF, Weideman P, Daly M, Andrieu N, John EM, Hooning MJ, Andrulis IL, Caldes T, Olsson H, Hopper JL
Format: Article
Language:English
Published: BMC 2012-04-01
Series:Hereditary Cancer in Clinical Practice
Online Access:http://www.hccpjournal.com/content/10/S2/A11

Internet

http://www.hccpjournal.com/content/10/S2/A11

Similar Items